Combination trastuzumab and chemotherapy to induce immunity to multiple tumor antigens in patients with HER2-positive metastatic breast cancer: NCCTG (Alliance) studies N0337 and N98-32-52.
Raphael Clynes
No relevant relationships to disclose
Keith L. Knutson
No relevant relationships to disclose
Karla V. Ballman
No relevant relationships to disclose
Courtney L. Erskine
No relevant relationships to disclose
Nadine Norton
No relevant relationships to disclose
Susan V. Sumrall
No relevant relationships to disclose
Donald W. Northfelt
No relevant relationships to disclose
Winston Tan
No relevant relationships to disclose
Carmen Julia Calfa
No relevant relationships to disclose
Mark D. Pegram
No relevant relationships to disclose
Edith A. Perez
No relevant relationships to disclose